Role of Hormones on Bundle-Specific ACL Function in the Growing Knee Joint
Project Number2R01AR071985-06A1
Former Number2R01AR071985-06
Contact PI/Project LeaderFISHER, MATTHEW B
Awardee OrganizationNORTH CAROLINA STATE UNIVERSITY RALEIGH
Description
Abstract Text
PROJECT SUMMARY
Anterior cruciate ligament (ACL) injuries impact more than 250,000 people in the U.S. annually. Sex is a major
risk factor for ACL injury during adolescence, but not in childhood or adulthood. To explain the increased injury
risk for females, several modifiable and non-modifiable risk factors have been explored. Very few of these studies
examine the impact on the ACL tissue itself, which in turn, can impact injury risk or the need for patient-specific
treatment. The long-term goal of our work is to explore mechanisms by which sex and skeletal growth impact
ACL structure, function, injury risk, and treatment. Our prior work has established sex- and region-specific
differences in function and cross-sectional area (CSA) within its anteromedial (AM) and posterolateral (PL)
bundles. These differences appear around early adolescence and persist as adolescence progresses. Yet, the
mechanism driving such sex-specific tissue adaptations is unclear. Earlier initiation of puberty has been
associated with greater cumulative estrogen exposure, which may influence ACL bundle function. Additionally,
ACL injury risk varies during the menstrual cycle in humans, but the presence of corresponding changes in ACL
bundle size and function is unknown. Additionally, a direct relationship between temporal hormone levels and
ACL size and function has not been established. Thus, the objective of this proposal is to determine how sex
hormones impact ACL bundle size and function. To accomplish this objective, we will leverage our multi-
disciplinary experience to accomplish the following aims. Aim 1 examines effect of puberty onset on long-term
ACL bundle size and function. In Aim 1a, we will assess how timing of natural puberty onset influences long-
term ACL bundle size and function throughout adolescence. In Aim 1b, we will assess whether early induction
of puberty and rise in estrogen further alters ACL bundle size and function throughout adolescence. Aim 2
examines the effect of cyclic hormone levels on short-term ACL bundle size and function. In Aim 2a, we will
assess how cyclic sex hormone levels influence ACL bundle size and function throughout the normal estrus
cycle. In Aim 2b, we will assess whether stabilization of hormone levels reduces cyclic changes in ACL bundle
size and function. If successful, this proposal will establish a clear and direct link between natural changes in
sex hormones during adolescence and ACL size or function. Ultimately, the information gained can suggest
promising human clinical trials of injury risk reduction and new potential treatment strategies.
Public Health Relevance Statement
RELEVANCE TO PUBLIC HEALTH
Injuries to the anterior cruciate ligament (ACL) of the knee joint are rising, particularly for the female adolescent
population, yet the mechanisms driving age- and sex-specific ACL tissue adaptations that may lead to increase
injury risk are unclear. The goal of this proposal is to determine how the timing and level of sex hormones impact
ACL bundle size and function. Such information will be critical to provide guidance for patient-specific injury risk
and treatment algorithms.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
CFDA Code
846
DUNS Number
042092122
UEI
U3NVH931QJJ3
XRPPWZ3TK937
Project Start Date
01-May-2018
Project End Date
30-April-2029
Budget Start Date
08-May-2024
Budget End Date
30-April-2025
Project Funding Information for 2024
Total Funding
$654,883
Direct Costs
$443,961
Indirect Costs
$210,922
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Arthritis and Musculoskeletal and Skin Diseases
$654,883
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2R01AR071985-06A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2R01AR071985-06A1
Patents
No Patents information available for 2R01AR071985-06A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2R01AR071985-06A1
Clinical Studies
No Clinical Studies information available for 2R01AR071985-06A1
News and More
Related News Releases
No news release information available for 2R01AR071985-06A1
History
No Historical information available for 2R01AR071985-06A1
Similar Projects
No Similar Projects information available for 2R01AR071985-06A1